ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 87

A Novel Histone Deacetylase 6 Inhibitor, CKD-M808, Regulates the Adhesion and Migration of Fibroblast-like Synoviocytes, and Enhances Suppressive Function of Regulatory T Cells in Rheumatoid Arthritis

Sehui Shon1, Ji Soo Park1, Shin Eui Kang1, Jeong Yeon Kim1, Dong-Hyeon Suh2, Daekwon Bae2, Nina Ha2, Young Il Choi2, Jin Kyun Park1,3, Eun Young Lee3, Eun Bong Lee3 and Yeong Wook Song3,4, 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Korea, Republic of (South), 2Research Institute of Chong Kun Dang Pharmaceutical Corporation, Yongin, Korea, Republic of (South), 3Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South), 4Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Koer, Seoul, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: regulatory cells and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster I: The Variable World of Intercellular Signalling

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by bone and cartilage destruction with leukocyte infiltration and activation at synovial tissue. Recently, upregulated histone deacetylase (HDAC) activity has been reported in peripheral blood mononuclear cells (PBMCs) from RA patients. In addition, it has been reported that HDAC inhibitor (HDACi) improved cancers, neurological diseases and inflammatory diseases by suppressing pro-inflammatory cytokines such as TNF-α and IL-6. Previously, we reported that a novel histone deacetylase 6 inhibitor (HDAC6i), CKD-M808 (M808) decreased clinical score in adjuvant induced arthritis (AIA) rat model. Here, we investigated the effect of M808 on cell adhesion, migration and suppressive function of regulatory T cells (Treg) derived from RA patients.

Methods:

Fibroblast-like synoviocytes (FLS) were isolated from synovial tissues of RA patients, and treated with HDAC6i such as tubastatin A and M808 under IL-1β stimulation. The expression of α-tubulin, acetylated tubulin, intracellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 were measured in RA FLS by western blotting. The levels of CCL2, CXCL8 and CXCL10 were measured in culture supernatant. Wound healing assay were performed to confirm cell migration ability. The adhesion of U937 or Jurkat cells onto RA FLS was measured by cell adhesion assay. CD4+CD25- T cells (effector T cells, Teff) were isolated from RA PBMCs, and differentiated into induced Treg (iTreg) under differentiating media. After the differentiation, Foxp3 and CTLA-4 were analyzed by flow cytometry. iTreg were also co-cultured with carboxyfluorescein succinmidyl ester (CFSE)-labeled Teff derived from healthy donor. The proliferation of Teff was analyzed by flow cytometry.

Results:

M808 increased the acetylation of tubulin in RA FLS. The number of migrated cell was decreased in M808-treated RA FLS without the change in cell viability. The expression of ICAM-1 and VCAM-1 were decreased in HDAC6i-treated groups in a dose-dependent manner. M808 reduced the levels of chemokines including CCL2, CXCL8 and CXCL10 in RA FLS. In addition, M808 attenuated the adhesion of U937 and Jurkat cells on RA FLS. The suppressive function of iTreg were significantly increased in M808-treated groups.

Conclusion:

M808 increased the acetylation of tubulin, and decreased the migration of RA FLS. M808 also decreased the expression of ICAM-1, VCAM-1 and chemokines such as CCL2, CXCL8 and CXCL10. The adhesion between RA FLS and U937 or Jurkat cells was decreased in the presence of M808. M808 increased the suppressive function of iTreg derived from RA PBMCs. The novel HDAC6i, M808, may provide a new therapeutic option in RA patients.


Disclosure: S. Shon, CKD Research Institute, 2; J. S. Park, None; S. E. Kang, None; J. Y. Kim, None; D. H. Suh, CKD Research Institute, 2; D. Bae, CKD Research Institute, 2; N. Ha, CKD Research Institute, 2; Y. I. Choi, CKD Research Institute, 2; J. K. Park, None; E. Y. Lee, None; E. B. Lee, None; Y. W. Song, CKD Research Institute, 2.

To cite this abstract in AMA style:

Shon S, Park JS, Kang SE, Kim JY, Suh DH, Bae D, Ha N, Choi YI, Park JK, Lee EY, Lee EB, Song YW. A Novel Histone Deacetylase 6 Inhibitor, CKD-M808, Regulates the Adhesion and Migration of Fibroblast-like Synoviocytes, and Enhances Suppressive Function of Regulatory T Cells in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-novel-histone-deacetylase-6-inhibitor-ckd-m808-regulates-the-adhesion-and-migration-of-fibroblast-like-synoviocytes-and-enhances-suppressive-function-of-regulatory-t-cells-in-rheumatoid-arth/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-histone-deacetylase-6-inhibitor-ckd-m808-regulates-the-adhesion-and-migration-of-fibroblast-like-synoviocytes-and-enhances-suppressive-function-of-regulatory-t-cells-in-rheumatoid-arth/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology